NO303585B1 - FremgangsmÕte til Õ bestemme hvorvidt et klinisk pr°vemateriale er egnet til bruk i nukleinsyrehybridiseringsfors°k og testkit for utf°relse av fremgangsmÕten - Google Patents
FremgangsmÕte til Õ bestemme hvorvidt et klinisk pr°vemateriale er egnet til bruk i nukleinsyrehybridiseringsfors°k og testkit for utf°relse av fremgangsmÕten Download PDFInfo
- Publication number
- NO303585B1 NO303585B1 NO922515A NO922515A NO303585B1 NO 303585 B1 NO303585 B1 NO 303585B1 NO 922515 A NO922515 A NO 922515A NO 922515 A NO922515 A NO 922515A NO 303585 B1 NO303585 B1 NO 303585B1
- Authority
- NO
- Norway
- Prior art keywords
- sample
- nucleic acid
- gel
- stated
- kit
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 34
- 238000007899 nucleic acid hybridization Methods 0.000 title claims abstract description 7
- 239000000523 sample Substances 0.000 title claims description 94
- 238000002474 experimental method Methods 0.000 title claims description 9
- 238000003149 assay kit Methods 0.000 title 1
- 238000012360 testing method Methods 0.000 claims abstract description 39
- 108020004414 DNA Proteins 0.000 claims abstract description 29
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 21
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 21
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 21
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 21
- 102000053602 DNA Human genes 0.000 claims abstract description 3
- 239000000499 gel Substances 0.000 claims description 32
- 239000000463 material Substances 0.000 claims description 30
- 239000011543 agarose gel Substances 0.000 claims description 15
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 claims description 14
- 229960005542 ethidium bromide Drugs 0.000 claims description 14
- 238000003780 insertion Methods 0.000 claims description 14
- 230000037431 insertion Effects 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 14
- 229920000936 Agarose Polymers 0.000 claims description 11
- 241000701806 Human papillomavirus Species 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 4
- 229920003023 plastic Polymers 0.000 claims description 4
- 229920002401 polyacrylamide Polymers 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 230000000007 visual effect Effects 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims 3
- 210000004392 genitalia Anatomy 0.000 claims 1
- 239000013641 positive control Substances 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 6
- 238000010186 staining Methods 0.000 abstract 4
- 238000009396 hybridization Methods 0.000 description 18
- 238000007790 scraping Methods 0.000 description 12
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 238000011179 visual inspection Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 208000009608 Papillomavirus Infections Diseases 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000000980 acid dye Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000003679 cervix uteri Anatomy 0.000 description 2
- 239000013043 chemical agent Substances 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 150000004775 coumarins Chemical class 0.000 description 2
- 239000012470 diluted sample Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000008393 encapsulating agent Substances 0.000 description 2
- 125000004387 flavanoid group Chemical group 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000009595 pap smear Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 2
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 101000875067 Homo sapiens Collagen alpha-2(I) chain Proteins 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001251 acridines Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229960002045 bergapten Drugs 0.000 description 1
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 108091092328 cellular RNA Proteins 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012468 concentrated sample Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- LIIALPBMIOVAHH-UHFFFAOYSA-N herniarin Chemical compound C1=CC(=O)OC2=CC(OC)=CC=C21 LIIALPBMIOVAHH-UHFFFAOYSA-N 0.000 description 1
- JHGVLAHJJNKSAW-UHFFFAOYSA-N herniarin Natural products C1CC(=O)OC2=CC(OC)=CC=C21 JHGVLAHJJNKSAW-UHFFFAOYSA-N 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000012296 in situ hybridization assay Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000000138 intercalating agent Substances 0.000 description 1
- 208000024312 invasive carcinoma Diseases 0.000 description 1
- XDROKJSWHURZGO-UHFFFAOYSA-N isopsoralen Natural products C1=C2OC=CC2=C2OC(=O)C=CC2=C1 XDROKJSWHURZGO-UHFFFAOYSA-N 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 150000005053 phenanthridines Chemical class 0.000 description 1
- 150000002988 phenazines Chemical class 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- MLMVLVJMKDPYBM-UHFFFAOYSA-N pseudoisopsoralene Natural products C1=C2C=COC2=C2OC(=O)C=CC2=C1 MLMVLVJMKDPYBM-UHFFFAOYSA-N 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011309 routine diagnosis Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60457590A | 1990-10-26 | 1990-10-26 | |
| PCT/FI1991/000321 WO1992007955A1 (en) | 1990-10-26 | 1991-10-25 | Method for evaluating the adequacy of clinical specimens for hybridization assays and kit for performing the evaluation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO922515D0 NO922515D0 (no) | 1992-06-25 |
| NO922515L NO922515L (no) | 1992-08-25 |
| NO303585B1 true NO303585B1 (no) | 1998-08-03 |
Family
ID=24420178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO922515A NO303585B1 (no) | 1990-10-26 | 1992-06-25 | FremgangsmÕte til Õ bestemme hvorvidt et klinisk pr°vemateriale er egnet til bruk i nukleinsyrehybridiseringsfors°k og testkit for utf°relse av fremgangsmÕten |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0507904B1 (fi) |
| JP (1) | JP2718823B2 (fi) |
| AT (1) | ATE176001T1 (fi) |
| AU (1) | AU643086B2 (fi) |
| CA (1) | CA2071935C (fi) |
| DE (1) | DE69130795T2 (fi) |
| DK (1) | DK0507904T3 (fi) |
| ES (1) | ES2129411T3 (fi) |
| FI (1) | FI99027C (fi) |
| GR (1) | GR3029345T3 (fi) |
| NO (1) | NO303585B1 (fi) |
| WO (1) | WO1992007955A1 (fi) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08501228A (ja) * | 1992-08-07 | 1996-02-13 | ジェンザイム・コーポレイション | 非液体細胞試料の採取方法 |
| CA2321100A1 (en) * | 1998-02-19 | 1999-08-26 | Edvotek | Articles of manufacture and methods for staining biomolecules |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5109429A (en) * | 1985-11-04 | 1992-04-28 | Cell Analysis Systems,Inc. | Apparatus and method for analyses of biological specimens |
| JP2681061B2 (ja) * | 1988-06-08 | 1997-11-19 | ロンドン・ダイアグノスティック・インコーポレーテッド | 検出可能なシグナルのセンシタイザー誘導発生を利用したアッセイ |
-
1991
- 1991-10-25 WO PCT/FI1991/000321 patent/WO1992007955A1/en active IP Right Grant
- 1991-10-25 AT AT91917738T patent/ATE176001T1/de not_active IP Right Cessation
- 1991-10-25 DK DK91917738T patent/DK0507904T3/da active
- 1991-10-25 JP JP3516421A patent/JP2718823B2/ja not_active Expired - Fee Related
- 1991-10-25 ES ES91917738T patent/ES2129411T3/es not_active Expired - Lifetime
- 1991-10-25 AU AU87127/91A patent/AU643086B2/en not_active Ceased
- 1991-10-25 EP EP91917738A patent/EP0507904B1/en not_active Expired - Lifetime
- 1991-10-25 CA CA002071935A patent/CA2071935C/en not_active Expired - Fee Related
- 1991-10-25 DE DE69130795T patent/DE69130795T2/de not_active Expired - Fee Related
-
1992
- 1992-06-24 FI FI922926A patent/FI99027C/fi not_active IP Right Cessation
- 1992-06-25 NO NO922515A patent/NO303585B1/no unknown
-
1999
- 1999-02-10 GR GR990400432T patent/GR3029345T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2071935A1 (en) | 1992-04-27 |
| ES2129411T3 (es) | 1999-06-16 |
| FI99027C (fi) | 1999-10-20 |
| DE69130795T2 (de) | 1999-07-08 |
| FI99027B (fi) | 1997-06-13 |
| JPH05502798A (ja) | 1993-05-20 |
| FI922926A (fi) | 1992-06-24 |
| NO922515L (no) | 1992-08-25 |
| CA2071935C (en) | 1996-06-11 |
| FI922926A0 (fi) | 1992-06-24 |
| EP0507904A1 (en) | 1992-10-14 |
| ATE176001T1 (de) | 1999-02-15 |
| DK0507904T3 (da) | 1999-09-13 |
| EP0507904B1 (en) | 1999-01-20 |
| GR3029345T3 (en) | 1999-05-28 |
| DE69130795D1 (de) | 1999-03-04 |
| AU8712791A (en) | 1992-05-26 |
| NO922515D0 (no) | 1992-06-25 |
| AU643086B2 (en) | 1993-11-04 |
| WO1992007955A1 (en) | 1992-05-14 |
| JP2718823B2 (ja) | 1998-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ahmed et al. | Comparison of current methods used to detect Cryptosporidium oocysts in stools | |
| AU2007203372B2 (en) | Universal collection medium | |
| Hamzah et al. | Development of multiplex real-time polymerase chain reaction for detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in clinical specimens | |
| Snijders et al. | HPV DNA detection and typing in cervical scrapes | |
| AU2004278730B2 (en) | Automated cytological sample classification | |
| EP1034040A2 (en) | Devices and methods for detecting target molecules in biological samples | |
| WO2011008030A2 (ko) | 핵산 검출용 크로마토그래피 시스템 | |
| JP2021100432A (ja) | 部分的溶解およびアッセイの方法 | |
| Tsang et al. | Canadian Public Health Laboratory Network laboratory guidelines for the use of direct tests to detect syphilis in Canada | |
| JP2003530830A (ja) | 微生物の計数および同定方法 | |
| Abdelsalam et al. | The impact of different copro-preservation conditions on molecular detection of Cryptosporidium species | |
| Iglesias et al. | Performance of a new gelled nested PCR test for the diagnosis of imported malaria: comparison with microscopy, rapid diagnostic test, and real-time PCR | |
| CN211339511U (zh) | 用于lamp或rt-lamp的一体化试纸条 | |
| Larsson et al. | A novel and simple method for laboratory diagnosis of relapsing fever borreliosis | |
| NO303585B1 (no) | FremgangsmÕte til Õ bestemme hvorvidt et klinisk pr°vemateriale er egnet til bruk i nukleinsyrehybridiseringsfors°k og testkit for utf°relse av fremgangsmÕten | |
| Khanaliha et al. | Comparison of three staining methods for the detection of intestinal Microspora spp | |
| Moyo et al. | Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation | |
| Kellogg et al. | Diff-Quik stain as a simplified alternative to Papanicolaou stain for determination of quality of endocervical specimens submitted for PCR detection of Chlamydia trachomatis | |
| US20050014133A1 (en) | Detection of human papilloma virus in papanicolaou (Pap) smears | |
| CN210340943U (zh) | 用于lamp或rt-lamp的整合一体式多联试纸条 | |
| Prétet et al. | Novaprep® Vial Test is a suitable liquid-based cytology medium for high risk human papillomavirus testing by Hybrid Capture 2 | |
| Van Dijk et al. | Improved resolution by mounting of tissue sections for laser microdissection | |
| Mazellier et al. | Papillomavirus genotyping on formaldehyde fixed paraffin-embedded tissues in vulvar intraepithelial neoplasia | |
| Viana et al. | Comparison of two DNA obtainment methods as alternative protocols for the detection of human malária parasites by nested PCR | |
| Hampl et al. | Alternative methods for DNA probing in diagnosis: Ligase chain reaction (LCR) |